About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Migraine Clinical Trials in Phoenix | 110 Studies

Clinical Trials MigrainePhoenix

Migraine Clinical Trials in Phoenix

Find 110 clinical trials for migraine near Phoenix, Arizona. Connect with research centers in your area.

All Migraine trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 110 trials

CompletedLong-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in AdolescentsThis study was designed to determine long-term safety of TREXIMET (sumatriptan/naproxen sodium) in adolescents for the acute treatment of migraine.NCT00488514·Gilbert, Arizona and 76 others

Migraine Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine HeadacheThe purpose of this study is to determine if zonisamide is effective as a preventative medication for individuals with migraine headache.NCT00055484·Huntsville, Alabama and 12 others

CompletedStudy to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With MigraineMigraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound.NCT05264129·Birmingham, Alabama and 36 others

CompletedPREMIUM Migraine TrialThe Purpose of this study is to evaluate the impact of percutaneous closure of a patent foramen ovale (PFO) (a hole in the heart), using the AMPLATZER PFO Occluder, on the…NCT00355056·Phoenix, Arizona and 29 others

CompletedStudy to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult ParticipantsStudy to Evaluate the Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine When Administered During the ProdromeNCT04492020·Birmingham, Alabama and 72 others

RecruitingA Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic MigraineIn this clinical trial, participants with chronic migraine will receive injections with Xeomin or Placebo into muscles of the head and neck.NCT07018713·Chandler, Arizona and 110 others

CompletedSafety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301)This study consists of a 4-week screening period, a 24-week treatment period for all participants, followed by a 28-week treatment period extension (to 52 weeks in total) for a…NCT03557333·Birmingham, Alabama and 35 others

RecruitingResponding With Evidence and Access for Childhood HeadachesThis comparative effectiveness study will clarify current first-line preventive treatment approaches for use by neurologists, psychologists, and primary care providers in the…NCT05889624·Birmingham, Alabama and 14 others

CompletedA Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of MigraineStudy STS101-002 is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of single doses of STS101…NCT03901482·Birmingham, Alabama and 116 others

CompletedEvaluation of Galcanezumab in the Prevention of Chronic MigraineThe main purpose of this study is to evaluate the efficacy of the study drug known as galcanezumab in participants with chronic migraine.NCT02614261·Phoenix, Arizona and 116 others

CompletedThree Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of MigraineThis is a prospective randomized, double-blind, placebo-controlled study in participants with disabling migraine (Migraine Disability Assessment (MIDAS) score ≥ 11).NCT02605174·Birmingham, Alabama and 94 others

TerminatedA Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine PreventionThe purpose of this is study is to compare the efficacy of BHV-3500 (zavegepant) to placebo as a preventive treatment for migraine, as measured by the reduction in the number of…NCT04804033·Phoenix, Arizona and 115 others

CompletedEfficacy and Safety Trial of Rimegepant for Migraine Prevention in AdultsThe purpose of this is study is to compare the efficacy of BHV-3000 (rimegepant) to placebo as a preventive treatment for migraine, as measured by the reduction in the number of…NCT03732638·Chandler, Arizona and 92 others

Active not recruitingA Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic MigraineThe main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age.NCT04616326·Huntsville, Alabama and 87 others

CompletedA Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic MigraineTo evaluate the efficacy and safety of Botulinum Toxin Type A versus placebo (normal saline) as headache prophylaxis in adolescents (children 12 to 17) with chronic migraine.NCT01662492·Phoenix, Arizona and 21 others

TerminatedA Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With MigraineThe reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.NCT04396236·Birmingham, Alabama and 151 others

CompletedEfficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in AdultsThis study will evaluate the efficacy, safety and tolerability of prophylactic (preventative) treatment with BOTOX® (onabotulinumtoxinA) compared to topiramate in adults with…NCT02191579·Phoenix, Arizona and 31 others

CompletedA Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month PeriodThe purpose of this study is to test the effect on blood pressure of sumatriptan and naproxen sodium combination tablets, tablets containing only sumatriptan, and tablets…NCT00792636·Chandler, Arizona and 48 others

TerminatedSpectacle Tints and Thin-Films for MigraineNearly all migraine sufferers report sensitivity to light during a headache and a significant proportion of sufferers report light sensitivity between attacks.NCT02720211·Phoenix, Arizona and 3 others

TerminatedA Study in Migraine PreventionThe primary objective of this study is to measure the change in frequency of migraine attacks per 28 days in migraine patients being treated orally with LY2300559 for 12 weeks.NCT01184508·Phoenix, Arizona and 11 others

PreviousPage 2 of 6Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia